ruxolitinib,temozolomide
incyte,novartis,merck
['ruxolitinib', 'gbm']
our phase 1 clinical trial of ruxolitinib, temozolomide and radiation shows promising efficacy in #glioblastoma. os of 18 months in umethylated mgmt gbm. #asco22 #btsm 
Chief Medical Oncology, Dep Director, Chief Scientific Officer, Miami Cancer Institute-interests brain tumors & pt education @baptisthealthSF #tweets are my own